Storage regulation of bioequivalence test data in controversy

Published: 2006-10-25 06:59:00

Updated: 2006-10-25 06:59:00

A lawmaker recently claimed the current notice of the Korea Food and Drug Administration (KFDA) on the storage of bioequivalence test data might be a culprit associated with the generic drug's efficacy fabrication.

The allegation came as Rep Moon hee of the National Assembly's Health and Welfa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK